AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
TRANSFORMING-GROWTH-FACTOR-BETA IS ESSENTIAL FOR SPINDLE-CELL CONVERSION OF MOUSE SKIN CARCINOMA IN-VIVO - IMPLICATIONS FOR TUMOR INVASION
Authors: PORTELLA G CUMMING SA LIDDELL J CUI W IRELAND H AKHURST RJ BALMAIN A
Citation: G. Portella et al., TRANSFORMING-GROWTH-FACTOR-BETA IS ESSENTIAL FOR SPINDLE-CELL CONVERSION OF MOUSE SKIN CARCINOMA IN-VIVO - IMPLICATIONS FOR TUMOR INVASION, Cell growth & differentiation, 9(5), 1998, pp. 393-404
A MUTATION IN THE THROMBOMODULIN GENE, (127)G TO A CODING FOR ALA25THR, AND THE RISK OF MYOCARDIAL-INFARCTION IN MEN
Authors: DOGGEN CJM KUNZ G ROSENDAAL FR LANE DA VOS HL STUBBS PJ CATS VM IRELAND H
Citation: Cjm. Doggen et al., A MUTATION IN THE THROMBOMODULIN GENE, (127)G TO A CODING FOR ALA25THR, AND THE RISK OF MYOCARDIAL-INFARCTION IN MEN, Thrombosis and haemostasis, 80(5), 1998, pp. 743-748
A HISTONE DEACETYLASE INHIBITOR INDUCES SENESCENCE BY AN INK4 AND P53-DEPENDENT MECHANISM
Authors: MUNRO J IRELAND H MORRISON V PARKINSON EK
Citation: J. Munro et al., A HISTONE DEACETYLASE INHIBITOR INDUCES SENESCENCE BY AN INK4 AND P53-DEPENDENT MECHANISM, British Journal of Cancer, 78, 1998, pp. 61-61
CLARIFICATION OF THE RISK FOR VENOUS THROMBOSIS ASSOCIATED WITH HEREDITARY PROTEIN-S DEFICIENCY BY INVESTIGATION OF A LARGE KINDRED WITH A CHARACTERIZED GENE DEFECT
Authors: SIMMONDS RE IRELAND H LANE DA ZOLLER B DEFRUTOS PG DAHLBACK B
Citation: Re. Simmonds et al., CLARIFICATION OF THE RISK FOR VENOUS THROMBOSIS ASSOCIATED WITH HEREDITARY PROTEIN-S DEFICIENCY BY INVESTIGATION OF A LARGE KINDRED WITH A CHARACTERIZED GENE DEFECT, Annals of internal medicine, 128(1), 1998, pp. 8
THROMBOMODULIN GENE-MUTATIONS IN MYOCARDIAL-INFARCTION
Authors: IRELAND H KUNZ G KYRIAKOULIS K STUBBS PJ LANE DA
Citation: H. Ireland et al., THROMBOMODULIN GENE-MUTATIONS IN MYOCARDIAL-INFARCTION, Thrombosis and haemostasis, 1997, pp. 7-7
THROMBOTIC RISK ASSOCIATED WITH PROTEIN-S (PS) GENE MUTATION AND AN EXPLANATION FOR THE FAMILIAL COEXISTENCE OF TYPE-I AND TYPE-III PS-DEFICIENT PHENOTYPES
Authors: SIMMONDS RE ZOLLER B IRELAND H THOMPSON E DEFRUTOS PG DAHLBACK B LANE DA
Citation: Re. Simmonds et al., THROMBOTIC RISK ASSOCIATED WITH PROTEIN-S (PS) GENE MUTATION AND AN EXPLANATION FOR THE FAMILIAL COEXISTENCE OF TYPE-I AND TYPE-III PS-DEFICIENT PHENOTYPES, Thrombosis and haemostasis, 1997, pp. 729-729
OVER-EXPRESSION OF BETA-ANTITHROMBIN IN FAMILIAL ANTITHROMBIN DEFICIENCY CAUSED BY AN ASN135 TO THR MUTATION
Authors: BAYSTON TA TRIPODI A MANNUCCI PM BOCK SC IRELAND H LANE DA
Citation: Ta. Bayston et al., OVER-EXPRESSION OF BETA-ANTITHROMBIN IN FAMILIAL ANTITHROMBIN DEFICIENCY CAUSED BY AN ASN135 TO THR MUTATION, Thrombosis and haemostasis, 1997, pp. 765-765
PROTEIN-S DEFICIENCY - A DATABASE OF MUTATIONS - FOR THE PLASMA COAGULATION INHIBITORS SUBCOMMITTEE OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE INTERNATIONAL-SOCIETY-ON-THROMBOSIS-AND-HEMOSTASIS
Authors: GANDRILLE S BORGEL D IRELAND H LANE DA SIMMONDS R REITSMA PH MANNHALTER C PABINGER I SAITO H SUZUKI K FORMSTONE C COOPER DN ESPINOSA Y SALA N BERNARDI F ALACH M
Citation: S. Gandrille et al., PROTEIN-S DEFICIENCY - A DATABASE OF MUTATIONS - FOR THE PLASMA COAGULATION INHIBITORS SUBCOMMITTEE OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE INTERNATIONAL-SOCIETY-ON-THROMBOSIS-AND-HEMOSTASIS, Thrombosis and haemostasis, 77(6), 1997, pp. 1201-1214
THROMBOMODULIN GENE-MUTATIONS ASSOCIATED WITH MYOCARDIAL-INFARCTION
Authors: IRELAND H KUNZ G KYRIAKOULIS K STUBBS PJ LANE DA
Citation: H. Ireland et al., THROMBOMODULIN GENE-MUTATIONS ASSOCIATED WITH MYOCARDIAL-INFARCTION, Circulation, 96(1), 1997, pp. 15-18
GENETIC AND PHENOTYPIC ANALYSIS OF A LARGE (122-MEMBER) PROTEIN S-DEFICIENT KINDRED PROVIDES AN EXPLANATION FOR THE FAMILIAL COEXISTENCE OFTYPE-I AND TYPE-III PLASMA PHENOTYPES
Authors: SIMMONDS RE ZOLLER B IRELAND H THOMPSON E DEFRUTOS PG DAHLBACK B LANE DA
Citation: Re. Simmonds et al., GENETIC AND PHENOTYPIC ANALYSIS OF A LARGE (122-MEMBER) PROTEIN S-DEFICIENT KINDRED PROVIDES AN EXPLANATION FOR THE FAMILIAL COEXISTENCE OFTYPE-I AND TYPE-III PLASMA PHENOTYPES, Blood, 89(12), 1997, pp. 4364-4370
PROTHROMBOTIC IMPORTANCE OF THE FACTOR-V LEIDEN GENOTYPE MUTATION IN ACUTE CORONARY SYNDROMES
Authors: STUBBS P IRELAND H NOBLE M BAYSTON T LANE D
Citation: P. Stubbs et al., PROTHROMBOTIC IMPORTANCE OF THE FACTOR-V LEIDEN GENOTYPE MUTATION IN ACUTE CORONARY SYNDROMES, HEART, 75(5), 1996, pp. 18-18
GENE-MUTATIONS IN 21 UNRELATED CASES OF PHENOTYPIC HETEROZYGOUS PROTEIN-C DEFICIENCY AND THROMBOSIS
Authors: IRELAND H THOMPSON E LANE DA CHAN LC CONARD J DECATERINA M ROCCO V DESTEFANO V LEONE G FINAZZI G HALIL O LAFFAN M MACHIN S WOODCOCK B
Citation: H. Ireland et al., GENE-MUTATIONS IN 21 UNRELATED CASES OF PHENOTYPIC HETEROZYGOUS PROTEIN-C DEFICIENCY AND THROMBOSIS, Thrombosis and haemostasis, 76(6), 1996, pp. 867-873
DIRECTED SEARCH FOR THROMBOMODULIN GENE-MUTATIONS
Authors: IRELAND H KYRIAKOULIS K KUNZ G LANE DA
Citation: H. Ireland et al., DIRECTED SEARCH FOR THROMBOMODULIN GENE-MUTATIONS, Haemostasis, 26, 1996, pp. 227-232
TGF-BETA-1 INHIBITS THE FORMATION OF BENIGN SKIN TUMORS, BUT ENHANCESPROGRESSION TO INVASIVE SPINDLE CARCINOMAS IN TRANSGENIC MICE
Authors: CUI W FOWLIS DJ BRYSON S DUFFIE E IRELAND H BALMAIN A AKHURST RJ
Citation: W. Cui et al., TGF-BETA-1 INHIBITS THE FORMATION OF BENIGN SKIN TUMORS, BUT ENHANCESPROGRESSION TO INVASIVE SPINDLE CARCINOMAS IN TRANSGENIC MICE, Cell, 86(4), 1996, pp. 531-542
PRENATAL-DIAGNOSIS IN COMBINED ANTITHROMBIN AND FACTOR-V GENE MUTATION
Authors: LANE DA AUBERGER K IRELAND H ROSCHER AA THEIN SL
Citation: Da. Lane et al., PRENATAL-DIAGNOSIS IN COMBINED ANTITHROMBIN AND FACTOR-V GENE MUTATION, British Journal of Haematology, 94(4), 1996, pp. 753-755
ORAL-CONTRACEPTIVES ENHANCE THE RISK OF CLINICAL MANIFESTATION OF VENOUS THROMBOSIS AT A YOUNG AGE IN FEMALES HOMOZYGOUS FOR FACTOR-V LEIDEN
Authors: RINTELEN C MANNHALTER C IRELAND H LANE DA KNOBL P LECHNER K PABINGER I
Citation: C. Rintelen et al., ORAL-CONTRACEPTIVES ENHANCE THE RISK OF CLINICAL MANIFESTATION OF VENOUS THROMBOSIS AT A YOUNG AGE IN FEMALES HOMOZYGOUS FOR FACTOR-V LEIDEN, British Journal of Haematology, 93(2), 1996, pp. 487-490
IDENTIFICATION OF 19 PROTEIN-S GENE-MUTATIONS IN PATIENTS WITH PHENOTYPIC PROTEIN-S DEFICIENCY AND THROMBOSIS
Authors: SIMMONDS RE IRELAND H KUNZ G LANE DA BHAVNANI M CASTAMAN G HAMBLEY H LAFFAN M OCONNOR N SAS G TEW CJ WALKER ID
Citation: Re. Simmonds et al., IDENTIFICATION OF 19 PROTEIN-S GENE-MUTATIONS IN PATIENTS WITH PHENOTYPIC PROTEIN-S DEFICIENCY AND THROMBOSIS, Blood, 88(11), 1996, pp. 4195-4204
FACTOR-V LEIDEN GENE MUTATION AND THROMBIN GENERATION IN RELATION TO THE DEVELOPMENT OF ACUTE STROKE
Authors: CATTO A CARTER A IRELAND H BAYSTON TA PHILIPPOU H BARRETT J LANE DA GRANT PJ
Citation: A. Catto et al., FACTOR-V LEIDEN GENE MUTATION AND THROMBIN GENERATION IN RELATION TO THE DEVELOPMENT OF ACUTE STROKE, Arteriosclerosis, thrombosis, and vascular biology, 15(6), 1995, pp. 783-785
THROMBOTIC RISK DURING PREGNANCY AND PUERPERIUM IN WOMEN WITH APC-RESISTANCE - EFFECTIVE SUBCUTANEOUS HEPARIN-PROPHYLAXIS IN A PREGNANT PATIENT
Authors: DESTEFANO V MASTRANGELO S PACIARONI K IRELAND H LANE DA SCIRPA P BIZZI B LEONE G
Citation: V. Destefano et al., THROMBOTIC RISK DURING PREGNANCY AND PUERPERIUM IN WOMEN WITH APC-RESISTANCE - EFFECTIVE SUBCUTANEOUS HEPARIN-PROPHYLAXIS IN A PREGNANT PATIENT, Thrombosis and haemostasis, 74(2), 1995, pp. 793-794
NOVEL MUTATIONS IN 17 FAMILIES WITH TYPE-I ANTITHROMBIN DEFICIENCY
Authors: CSURGAY E IRELAND H THOMPSON E CONARD J MANNUCCI PM ANDREWS V WORSLEY A SAS G LANE DA
Citation: E. Csurgay et al., NOVEL MUTATIONS IN 17 FAMILIES WITH TYPE-I ANTITHROMBIN DEFICIENCY, Thrombosis and haemostasis, 73(6), 1995, pp. 935-935
GENE-MUTATIONS IN 26 FAMILIES WITH PROTEIN-C DEFICIENCY
Authors: IRELAND H THOMPSON E CONARD J FINAZZI G DESTEFANO V LEONE G DECATERINA M HALIL O STIRLING Y LANE DA
Citation: H. Ireland et al., GENE-MUTATIONS IN 26 FAMILIES WITH PROTEIN-C DEFICIENCY, Thrombosis and haemostasis, 73(6), 1995, pp. 937-937
CLINICAL-FEATURE IN PATIENTS WITH HOMOZYGOUS AND HETEROZYGOUS FACTOR-V LEIDEN MUTATION (APC-RESISTANCE) AND A HISTORY OF VENOUS THROMBOEMBOLISM
Authors: RINTELEN C BAYSTON TA IRELAND H LANE DA MANNHALTER C PABINGER I
Citation: C. Rintelen et al., CLINICAL-FEATURE IN PATIENTS WITH HOMOZYGOUS AND HETEROZYGOUS FACTOR-V LEIDEN MUTATION (APC-RESISTANCE) AND A HISTORY OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 73(6), 1995, pp. 1124-1124
FACTOR-V LEIDEN AS AN INDEPENDENT RISK FACTOR FOR THROMBOSIS IN ANTITHROMBIN DEFICIENCY TYPE-II - HEPARIN-BINDING SITE
Authors: IRELAND H BAYSTON TA CHOWDHURY V THEIN SL CONARD J PABINGER I LANE DA
Citation: H. Ireland et al., FACTOR-V LEIDEN AS AN INDEPENDENT RISK FACTOR FOR THROMBOSIS IN ANTITHROMBIN DEFICIENCY TYPE-II - HEPARIN-BINDING SITE, Thrombosis and haemostasis, 73(6), 1995, pp. 1361-1361
PREVALENCE OF APC-RESISTANCE IN PATIENTS WITH VENOUS THROMBOTIC DISEASE
Authors: DESTEFANO V MASTRANGELO S PACIARONI K IRELAND H LANE DA BIZZI B LEONE G
Citation: V. Destefano et al., PREVALENCE OF APC-RESISTANCE IN PATIENTS WITH VENOUS THROMBOTIC DISEASE, Thrombosis and haemostasis, 73(6), 1995, pp. 1370-1370
EVALUATION OF ACTIVATED PROTEIN-C RESISTANCE IN PATIENTS WITH ANTICOAGULANT TREATMENT
Authors: TROSSAERT M CONARD J HORELLOU MH IRELAND H BAYSTON TA LANE DA
Citation: M. Trossaert et al., EVALUATION OF ACTIVATED PROTEIN-C RESISTANCE IN PATIENTS WITH ANTICOAGULANT TREATMENT, Thrombosis and haemostasis, 73(6), 1995, pp. 1372-1372
Risultati: 1-25 | 26-38